Ropes & Gray advised Allorion Therapeutics on the transaction. Allorion Therapeutics (Allorion) announced it entered into a global licensing agreement with Avenzo Therapeutics Inc. (Avenzo) to develop and...
You must be a Standard 1 Year member to access this content.
Ropes & Gray LLP acted as legal advisor to NSC, while Milbank LLP and Wachtell, Lipton, Rosen & Katz acted as legal advisors to U. S....
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell and Eversheds Sutherland are advising Veoneer and SSW on the transaction. Ropes & Gray is advising AIP and Baker Botts LLP is...
You must be a Standard 1 Year member to access this content.
Wachtell, Lipton, Rosen & Katz served as legal advisor to AbbVie, while Ropes & Gray served as legal advisor to ImmunoGen. AbbVie Inc. (NYSE: ABBV) and...
You must be a Standard 1 Year member to access this content.
Squire Patton Boggs advised Taiwania Capital on the investment. Taiwanese venture capital fund Taiwania Capital completed the Series A investment in Vrgineers, a Czech-based developer of...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented LianBio on the deal. LianBio (Nasdaq: LIAN) announced it has entered into an agreement with Bristol Myers Squibb (NYSE:BMY)(BMS), whereby BMS has obtained...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented ImmunoGen in the deal. ImmunoGen, Inc. (Nasdaq: IMGN) announced it has entered into an exclusive collaboration with Takeda Pharmaceutical Company Limited (TSE:...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Advent International on the sale. Nestlé announced an agreement with Advent International to acquire a majority stake in Grupo CRM.. The transaction...
You must be a Standard 1 Year member to access this content.
Ropes & Gray acted as legal advisor to TransMedics, and Cooley acted as legal advisor to Bridge to Life. TransMedics Group, Inc. (Nasdaq: TMDX) announced that is...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Pfizer on the deal. Pfizer announced a strategic collaboration with Flagship Pioneering to create a new pipeline of innovative medicines. The collaboration...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Pfizer on the deal. Pfizer announced its strategic investment in and collaboration with CellCentric, which includes $25 million to help finance further development...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Gauge Capital in the deal. Gauge Capital announced its strategic partnership and recapitalization of Loving Tan. As part of the investment, Gauge will...
You must be a Standard 1 Year member to access this content.
